QUADRANT CAPITAL GROUP LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$12,628
+1242.0%
657
+1675.7%
0.00%
Q2 2023$941
-93.4%
37
-90.6%
0.00%
-100.0%
Q1 2023$14,280
+89.8%
395
+107.9%
0.00%0.0%
Q4 2022$7,524
-65.8%
190
-59.2%
0.00%
-66.7%
Q3 2022$22,000
+46.7%
466
+40.8%
0.00%
+50.0%
Q2 2022$15,000
+7.1%
331
+68.0%
0.00%0.0%
Q1 2022$14,000
-53.3%
197
-46.5%
0.00%
-50.0%
Q4 2021$30,000
+25.0%
368
+79.5%
0.00%
+33.3%
Q3 2021$24,000
-14.3%
205
+20.6%
0.00%
-25.0%
Q2 2021$28,0000.0%170
-14.6%
0.00%
-20.0%
Q1 2021$28,000
-3.4%
199
+17.1%
0.01%0.0%
Q4 2020$29,000
+20.8%
1700.0%0.01%0.0%
Q3 2020$24,000
+20.0%
1700.0%0.01%
+25.0%
Q2 2020$20,000
+17.6%
170
+1.8%
0.00%
+33.3%
Q1 2020$17,000
-10.5%
1670.0%0.00%
+50.0%
Q4 2019$19,000
+35.7%
1670.0%0.00%0.0%
Q3 2019$14,000
+40.0%
1670.0%0.00%0.0%
Q2 2019$10,0000.0%1670.0%0.00%0.0%
Q1 2019$10,000
+66.7%
1670.0%0.00%0.0%
Q4 2018$6,000
-14.3%
167
+75.8%
0.00%0.0%
Q2 2018$7,000
-12.5%
950.0%0.00%
-33.3%
Q1 2018$8,000950.00%
Other shareholders
NEVRO CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders